We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
-0.31%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$2.71B
AUM Growth
-$105M
Cap. Flow
-$29.7M
Cap. Flow %
-1.1%
Top 10 Hldgs %
23.72%
Holding
332
New
19
Increased
70
Reduced
176
Closed
23

Top Buys

Rank Stock Value
1
GXO icon
GXO Logistics
GXO
+$23.9M
2
SNBR
Sleep Number
SNBR
+$17.4M
3
BBBY
Bed Bath & Beyond
BBBY
+$7.08M
4
IAA
IAA, Inc. Common Stock
IAA
+$5.96M
5
BVS icon
Bioventus
BVS
+$5.71M

Top Sells

Rank Stock Value
1
XPO icon
XPO
XPO
+$20.8M
2
ZD icon
Ziff Davis
ZD
+$9.39M
3
NKTR icon
Nektar Therapeutics
NKTR
+$8.49M
4
POOL icon
Pool Corp
POOL
+$7.21M
5
INOV
Inovalon Holdings, Inc. Class A Common Stock
INOV
+$7.06M

Sector Composition

Rank Sector Weight
1 Technology 25.75%
2 Healthcare 24.54%
3 Industrials 15.71%
4 Consumer Discretionary 13.79%
5 Communication Services 6.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NOG icon
301
Northern Oil and Gas
NOG
$2.56B
$234K 0.01%
+10,938
New +$191K
LXP icon
302
LXP Industrial Trust
LXP
$3.58B
$232K 0.01%
3,631
– –
WKC icon
303
World Kinect Corp
WKC
$1.89B
$232K 0.01%
6,903
– –
CACI icon
304
CACI
CACI
$14.3B
$230K 0.01%
877
– –
BMY icon
305
Bristol-Myers Squibb
BMY
$132B
$229K 0.01%
3,870
– –
GWB
306
DELISTED
Great Western Bancorp, Inc.
GWB
$212K 0.01%
6,461
– –
RRX icon
307
Regal Rexnord
RRX
$11.5B
$206K 0.01%
+1,373
New +$197K
MRSH
308
Marsh
MRSH
$91B
$204K 0.01%
+1,350
New +$204K
APLE icon
309
Apple Hospitality REIT
APLE
$3.71B
$160K 0.01%
10,175
– –
AIRG icon
310
Airgain
AIRG
$71.7M
– –
-97,704
Closed -$2.02M
AVA icon
311
Avista
AVA
$3.2B
– –
-4,914
Closed -$210K
CHRS icon
312
Coherus Oncology
CHRS
$192M
– –
-213,748
Closed -$2.96M
COHR icon
313
Coherent
COHR
$63.6B
– –
-3,717
Closed -$270K
DLX icon
314
Deluxe
DLX
$1.12B
– –
-5,161
Closed -$247K
EFSC icon
315
Enterprise Financial Services Corp
EFSC
$2.38B
– –
-4,325
Closed -$201K
INGN icon
316
Inogen
INGN
$163M
– –
-46,044
Closed -$3M
KRMD icon
317
KORU Medical Systems
KRMD
$157M
– –
-441,459
Closed -$2.04M
MGNI icon
318
Magnite
MGNI
$3.47B
– –
-58,847
Closed -$1.99M
MRCY icon
319
Mercury Systems
MRCY
$6.52B
– –
-34,581
Closed -$2.29M
NKTR icon
320
Nektar Therapeutics
NKTR
$2.53B
– –
-32,971
Closed -$8.49M
OHI icon
321
Omega Healthcare
OHI
$14.4B
– –
-6,312
Closed -$229K
OSK icon
322
Oshkosh
OSK
$9.59B
– –
-1,915
Closed -$239K
OSPN icon
323
OneSpan
OSPN
$603M
– –
-91,474
Closed -$2.34M
PPBI
324
DELISTED
Pacific Premier Bancorp
PPBI
– –
-54,639
Closed -$2.31M
TER icon
325
Teradyne
TER
$57.1B
– –
-1,500
Closed -$201K
10 11 12
13
14

Similar funds

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM

Rice Hall James & Associates's Q3 2021 Portfolio in Review

As of Q3 2021, Rice Hall James & Associates held 332 positions worth $2.71B, down 3.7% from $2.81B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Rice Hall James & Associates's Q3 2021 filing shows 19 new, 70 increased, 176 reduced and 23 closed positions. Its largest new stake was GXO Logistics: 305,297 shares worth $23.9M. The largest sale was XPO, an estimated $20.8M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Industrials.

  • Rice Hall James & Associates's largest Q3 2021 buy was GXO Logistics: 305,297 shares worth $23.9M.
  • Rice Hall James & Associates added most to Bed Bath & Beyond in Q3 2021, an estimated $7.08M increase.
  • Rice Hall James & Associates's biggest Q3 2021 reduction was XPO, cutting an estimated $20.8M.
  • Rice Hall James & Associates fully exited Nektar Therapeutics in Q3 2021, selling an estimated $8.49M.
  • Rice Hall James & Associates's ten largest holdings make up 24% of its $2.71B portfolio in Q3 2021.
  • Rice Hall James & Associates opened 19 new positions and closed 23 in Q3 2021.
  • Rice Hall James & Associates's portfolio value fell 3.7% quarter-over-quarter to $2.71B.

Based on Rice Hall James & Associates's 13F filing for Q3 2021, filed 9 Nov 2021.